167 related articles for article (PubMed ID: 27861750)
1. Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.
Somnay YR; Yu XM; Lloyd RV; Leverson G; Aburjania Z; Jang S; Jaskula-Sztul R; Chen H
Cancer; 2017 Mar; 123(5):769-782. PubMed ID: 27861750
[TBL] [Abstract][Full Text] [Related]
2. Notch3 as a novel therapeutic target in metastatic medullary thyroid cancer.
Lou I; Odorico S; Yu XM; Harrison A; Jaskula-Sztul R; Chen H
Surgery; 2018 Jan; 163(1):104-111. PubMed ID: 29128180
[TBL] [Abstract][Full Text] [Related]
3. Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction.
Jaskula-Sztul R; Eide J; Tesfazghi S; Dammalapati A; Harrison AD; Yu XM; Scheinebeck C; Winston-McPherson G; Kupcho KR; Robers MB; Hundal AK; Tang W; Chen H
Mol Cancer Ther; 2015 Feb; 14(2):499-512. PubMed ID: 25512616
[TBL] [Abstract][Full Text] [Related]
4. Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN.
Zhang YQ; Liang YK; Wu Y; Chen M; Chen WL; Li RH; Zeng YZ; Huang WH; Wu JD; Zeng D; Gao WL; Chen CF; Lin HY; Yang RQ; Zhu JW; Liu WL; Bai JW; Wei M; Wei XL; Zhang GJ
Cell Death Dis; 2021 May; 12(6):502. PubMed ID: 34006834
[TBL] [Abstract][Full Text] [Related]
5. The Notch3 Receptor and Its Intracellular Signaling-Dependent Oncogenic Mechanisms.
Bellavia D; Checquolo S; Palermo R; Screpanti I
Adv Exp Med Biol; 2018; 1066():205-222. PubMed ID: 30030828
[TBL] [Abstract][Full Text] [Related]
6. Notch3-specific inhibition using siRNA knockdown or GSI sensitizes paclitaxel-resistant ovarian cancer cells.
Kang H; Jeong JY; Song JY; Kim TH; Kim G; Huh JH; Kwon AY; Jung SG; An HJ
Mol Carcinog; 2016 Jul; 55(7):1196-209. PubMed ID: 26207830
[TBL] [Abstract][Full Text] [Related]
7. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibitor of Notch‑3 enhances the sensitivity of NSCLC cells to gemcitabine.
Hu BD; Guo J; Ye YZ; Du T; Cheng CS; Jiang Q; Liu RN; Zhang YB
Oncol Rep; 2018 Jul; 40(1):155-164. PubMed ID: 29781034
[TBL] [Abstract][Full Text] [Related]
9. Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression.
Franciosa G; Diluvio G; Gaudio FD; Giuli MV; Palermo R; Grazioli P; Campese AF; Talora C; Bellavia D; D'Amati G; Besharat ZM; Nicoletti C; Siebel CW; Choy L; Rustighi A; Sal GD; Screpanti I; Checquolo S
Oncogene; 2016 Sep; 35(36):4741-51. PubMed ID: 26876201
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer.
Cai H; Yao J; An Y; Chen X; Chen W; Wu D; Luo B; Yang Y; Jiang Y; Sun D; He X
Oncotarget; 2017 May; 8(20):32905-32917. PubMed ID: 28415631
[TBL] [Abstract][Full Text] [Related]
12. Constitutive NOTCH3 Signaling Promotes the Growth of Basal Breast Cancers.
Choy L; Hagenbeek TJ; Solon M; French D; Finkle D; Shelton A; Venook R; Brauer MJ; Siebel CW
Cancer Res; 2017 Mar; 77(6):1439-1452. PubMed ID: 28108512
[TBL] [Abstract][Full Text] [Related]
13. Low expression of long noncoding RNA CASC2 indicates a poor prognosis and promotes tumorigenesis in thyroid carcinoma.
Xiong X; Zhu H; Chen X
Biomed Pharmacother; 2017 Sep; 93():391-397. PubMed ID: 28654795
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells.
Yang SL; Ren QG; Zhang T; Pan X; Wen L; Hu JL; Yu C; He QJ
Oncol Rep; 2017 Jan; 37(1):348-356. PubMed ID: 27840976
[TBL] [Abstract][Full Text] [Related]
15. Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
Jung JG; Stoeck A; Guan B; Wu RC; Zhu H; Blackshaw S; Shih IeM; Wang TL
PLoS Genet; 2014 Oct; 10(10):e1004751. PubMed ID: 25356737
[TBL] [Abstract][Full Text] [Related]
16. Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of Notch3.
Zou B; Wang H; Liu Y; Qi P; Lei T; Sun M; Wang Y
Oncol Rep; 2017 Sep; 38(3):1431-1441. PubMed ID: 28714011
[TBL] [Abstract][Full Text] [Related]
17. Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma.
Zhang H; Liu L; Liu C; Pan J; Lu G; Zhou Z; Chen Z; Qian C
Oncotarget; 2017 May; 8(21):34362-34373. PubMed ID: 28416766
[TBL] [Abstract][Full Text] [Related]
18. Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.
Gupta N; Xu Z; El-Sehemy A; Steed H; Fu Y
Gynecol Oncol; 2013 Jul; 130(1):200-6. PubMed ID: 23542683
[TBL] [Abstract][Full Text] [Related]
19. Expression of YY1 in Differentiated Thyroid Cancer.
Arribas J; Castellví J; Marcos R; Zafón C; Velázquez A
Endocr Pathol; 2015 May; 26(2):111-8. PubMed ID: 25698133
[TBL] [Abstract][Full Text] [Related]
20. Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.
Bernasconi-Elias P; Hu T; Jenkins D; Firestone B; Gans S; Kurth E; Capodieci P; Deplazes-Lauber J; Petropoulos K; Thiel P; Ponsel D; Hee Choi S; LeMotte P; London A; Goetcshkes M; Nolin E; Jones MD; Slocum K; Kluk MJ; Weinstock DM; Christodoulou A; Weinberg O; Jaehrling J; Ettenberg SA; Buckler A; Blacklow SC; Aster JC; Fryer CJ
Oncogene; 2016 Nov; 35(47):6077-6086. PubMed ID: 27157619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
